Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Belite Bio, Inc (BLTE) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Belite Bio, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1889109.
Total stock buying since 2026: $0.
Total stock sales since 2026: $2,998,242.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 16,500 | $2,998,242 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-04 | 0 | $0 | 16,500 | $2,998,242 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-09 | Chen Wan-shan | Sale | 1,100 | 180.43 | 198,473 |
| 2026-04-09 | Chuang Hao-yuan (Chief Financial Officer) | Sale | 6,200 | 181.85 | 1,127,476 |
| 2026-04-09 | Lin Yu-hsin (Chief Executive Officer) | Sale | 9,200 | 181.77 | 1,672,293 |
Insider trading activities including stock purchases, stock sales, and option exercises of BLTE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Belite Bio, Inc (symbol BLTE, CIK number 1889109) see the Securities and Exchange Commission (SEC) website.